Healthcare provider profile · identity verified

Claudia Cabrera Hernandez, MD

Allopathic & Osteopathic Physicians|Internal Medicine · NORTH MIAMI BEACH, FL · NPI 1285196782

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Claudia Cabrera Hernandez, MD received $59.16 in general payments during 2025 across 2 reported records.

ViiV Healthcare Company accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$59.16

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ViiV Healthcare Company	Unresolved — no canonical attribution shown	$59.16	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$59.16	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	551	198
Rosuvastatin Calcium	Rosuvastatin Calcium	454	175
Diclofenac Sodium	Diclofenac Sodium	387	184
Losartan Potassium	Losartan Potassium	371	140
Amlodipine Besylate	Amlodipine Besylate	358	134
Metformin Hcl	Metformin Hcl	357	130
Fluticasone Propionate	Fluticasone Propionate	299	147
Albuterol Sulfate Hfa	Albuterol Sulfate	284	133
Levothyroxine Sodium	Levothyroxine Sodium	263	98
Lisinopril	Lisinopril	237	82
Azithromycin	Azithromycin	228	166
Omeprazole	Omeprazole	206	112
Pantoprazole Sodium	Pantoprazole Sodium	202	95
Ibuprofen	Ibuprofen	182	103
Gabapentin	Gabapentin	181	93
Famotidine	Famotidine	172	82
Glipizide	Glipizide	166	56
Ozempic	Semaglutide	158	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	149	83
Methylprednisolone	Methylprednisolone	135	105
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	131	102
Metoprolol Succinate	Metoprolol Succinate	131	58
Montelukast Sodium	Montelukast Sodium	130	76
Hydrochlorothiazide	Hydrochlorothiazide	127	57
Baclofen	Baclofen	119	84
Alendronate Sodium	Alendronate Sodium	111	51
Metoprolol Tartrate	Metoprolol Tartrate	106	44
Triamcinolone Acetonide	Triamcinolone Acetonide	99	62
Furosemide	Furosemide	89	37
Tamsulosin Hcl	Tamsulosin Hcl	88	50
Eliquis	Apixaban	84	29
Nifedipine Er	Nifedipine	82	39
Carvedilol	Carvedilol	81	33
Ketoconazole	Ketoconazole	75	30
Escitalopram Oxalate	Escitalopram Oxalate	70	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	23
Farxiga	Dapagliflozin Propanediol	63	17
Ammonium Lactate	Ammonium Lactate	62	20
Tramadol Hcl	Tramadol Hcl	61	40
Simvastatin	Simvastatin	60	23
Atenolol	Atenolol	59	22
Trazodone Hcl	Trazodone Hcl	59	30
Jardiance	Empagliflozin	58	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	17
Zolpidem Tartrate	Zolpidem Tartrate	55	14
Clopidogrel	Clopidogrel Bisulfate	54	24
Sildenafil Citrate	Sildenafil Citrate	53	17
Ezetimibe	Ezetimibe	51	23
Doxycycline Monohydrate	Doxycycline Monohydrate	49	41
Pravastatin Sodium	Pravastatin Sodium	49	20
Vitamin D2	Ergocalciferol (Vitamin D2)	48	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	47	17
Glimepiride	Glimepiride	41	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	13
Alprazolam	Alprazolam	39	11
Latanoprost	Latanoprost	39	13
Loperamide	Loperamide Hcl	38	22
Donepezil Hcl	Donepezil Hcl	37	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	12
Lorazepam	Lorazepam	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	13
Januvia	Sitagliptin Phosphate	35	11
Meclizine Hcl	Meclizine Hcl	35	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	34
Meloxicam	Meloxicam	34	22
Pioglitazone Hcl	Pioglitazone Hcl	34	12
Clobetasol Propionate	Clobetasol Propionate	33	16
Clonazepam	Clonazepam	33	suppressed
Ondansetron Odt	Ondansetron	33	22
Ciclopirox	Ciclopirox	32	18
Folic Acid	Folic Acid	32	11
Novolog Flexpen	Insulin Aspart	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	18
Enalapril Maleate	Enalapril Maleate	29	11
Lactulose	Lactulose	29	18
Trulicity	Dulaglutide	29	suppressed
Finasteride	Finasteride	28	13
Metformin Hcl Er	Metformin Hcl	28	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Valsartan	Valsartan	27	11
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fluconazole	Fluconazole	26	17
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Hydrocortisone	Hydrocortisone	25	11
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	25	18
Benazepril Hcl	Benazepril Hcl	24	suppressed
Ciclopirox	Ciclopirox Olamine	24	12
Citalopram Hbr	Citalopram Hydrobromide	24	12
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Allopurinol	Allopurinol	23	11
Irbesartan	Irbesartan	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	12
Telmisartan	Telmisartan	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Prednisone	Prednisone	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Mounjaro	Tirzepatide	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	17	suppressed
Metronidazole	Metronidazole	17	14
Potassium Chloride	Potassium Chloride	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Novolin N	Insulin Nph Human Isophane	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	14	suppressed
Humira(Cf) Pen	Adalimumab	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Synthroid	Levothyroxine Sodium	14	suppressed
Linzess	Linaclotide	13	suppressed
Nystatin	Nystatin	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Colchicine	Colchicine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Lidocaine	Lidocaine	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$59.16 · 2 records	ViiV Healthcare Company	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error